Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Masur

Showing results (181-190 of 292) with videos related to

Pageof 30
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1988
Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolateJ A Kovacs, C J Allegra, J C Swan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Quality standard for the enumeration of CD4+ lymphocytes in infants and children exposed to or infected with human immunodeficiency virusC M Wilfert, P A Gross, J E Kaplan, et al.
Annals of Internal Medicine|September 1, 1992
NIH conference. Respiratory disease in the immunosuppressed patientJ H Shelhamer, G B Toews, H Masur, et al.
Annals of Internal Medicine|January 1, 1984
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerationsA S Fauci, A M Macher, D L Longo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in infants and children born to women infected with human immunodeficiency virusC M Wilfert, H Masur, P A Gross, et al.
Journal of Biological Response Modifiers|October 1, 1984
Use of interleukin-2 in patients with acquired immunodeficiency syndromeH C Lane, J P Siegel, A H Rook, et al.
The American Journal of Medicine|March 1, 1988
Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndromeP L Rogers, R E Walker, H C Lane, et al.
Annals of Internal Medicine|March 15, 1996
The laboratory evaluation of opportunistic pulmonary infectionsJ H Shelhamer, V J Gill, T C Quinn, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1988
Efficacy of trimetrexate, a potent lipid-soluble antifolate, in the treatment of rodent Pneumocystis carinii pneumoniaJ A Kovacs, C J Allegra, S Kennedy, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndromeC R Horsburgh, D L Cohn, R B Roberts, et al.
Pageof 30

Showing results (181-190 of 292) with videos related to

Sort By:
Pageof 30
Antimicrobial Agents and Chemotherapy|April 1, 1988
Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolateJ A Kovacs, C J Allegra, J C Swan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Quality standard for the enumeration of CD4+ lymphocytes in infants and children exposed to or infected with human immunodeficiency virusC M Wilfert, P A Gross, J E Kaplan, et al.
Annals of Internal Medicine|September 1, 1992
NIH conference. Respiratory disease in the immunosuppressed patientJ H Shelhamer, G B Toews, H Masur, et al.
Annals of Internal Medicine|January 1, 1984
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerationsA S Fauci, A M Macher, D L Longo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in infants and children born to women infected with human immunodeficiency virusC M Wilfert, H Masur, P A Gross, et al.
Journal of Biological Response Modifiers|October 1, 1984
Use of interleukin-2 in patients with acquired immunodeficiency syndromeH C Lane, J P Siegel, A H Rook, et al.
The American Journal of Medicine|March 1, 1988
Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndromeP L Rogers, R E Walker, H C Lane, et al.
Annals of Internal Medicine|March 15, 1996
The laboratory evaluation of opportunistic pulmonary infectionsJ H Shelhamer, V J Gill, T C Quinn, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1988
Efficacy of trimetrexate, a potent lipid-soluble antifolate, in the treatment of rodent Pneumocystis carinii pneumoniaJ A Kovacs, C J Allegra, S Kennedy, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndromeC R Horsburgh, D L Cohn, R B Roberts, et al.
Pageof 30